ASN
ABCL icon

Advisory Services Network’s AbCellera Biologics ABCL Stock Holding History

Advisory Services Network’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3K Sell
2,962
-26,702
-90% -$96.1K ﹤0.01% 3542
2025
Q4 		$101K Buy
29,664
+3,386
+13% +$15.1K ﹤0.01% 1753
2025
Q3 		$132K Buy
+26,278
New +$116K ﹤0.01% 1919

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisory Services Network's ABCL Position: Q1 2026 in Review

Advisory Services Network reduced its AbCellera Biologics (ABCL) stake by 90% in Q1 2026, selling an estimated $96.1K and leaving 2,962 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Advisory Services Network first reported a position in ABCL in Q3 2025 and has held it in 3 quarters since. The position peaked at $132K in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Advisory Services Network held 2,962 shares of AbCellera Biologics worth $10.3K as of Q1 2026.
  • Advisory Services Network sold 26,702 AbCellera Biologics shares in Q1 2026, an estimated $96.1K.
  • AbCellera Biologics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3542 holding.
  • Advisory Services Network first reported a position in AbCellera Biologics in Q3 2025 and has held it in 3 quarters since.
  • Advisory Services Network's AbCellera Biologics position peaked at $132K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.